Join Accolade CEO, Rajeev Singh as he shares the value of personalized advocacy for employers’ bottom lines and their employees’ health outcomes.
Speaking Session: Wednesday, November 28, 2018 | 3:50-4:10pm EST
About the Conference
Now a three-day event, this year’s conference will feature more than 300 of the most highly regarded and influential companies across biotechnology, specialty pharmaceuticals, medical technology, medical diagnostics, life science tools, healthcare services and information technology sectors. The conference attracts an audience approaching 2,000 attendees including institutional investors from the U.S., Asia, Europe and Canada. Industry experts, physicians and academicians have also been invited to host panels and address regulatory, reimbursement and legal issues. Discussions about specific diseases, including atherosclerosis, diabetes and cancer, will provide critical insights to investors.